Terry Flotte, MD, steps down as ASGCT president at the end of this week. In this exclusive interview, Terry shares the ...

New capsids Dyno-9zh and Dyno-n96 for central nervous system (CNS) and muscular gene delivery expand Dyno's portfolio of AI-engineered vectors and create more delivery options for therapeutic ...

An accidental leak revealed the existence of Claude Mythos, an AI model capable of autonomously detecting and exploiting ...

AI, especially generative AI, is transforming medical education by changing how trainees learn, synthesize information, and ...

Detailed price information for Lavras Gold Corp (LGC-X) from The Globe and Mail including charting and trades.

Bio-Techne Corporation ( TECH) Q3 2026 Earnings Call May 6, 2026 9:00 AM EDT Good morning, and welcome to the Bio-Techne Earnings Conference Call for the Third Quarter and Fiscal Year 2026. [Operator ...

MicroCloud Hologram Inc. (NASDAQ: HOLO), (“HOLO” or the "Company"), a technology service provider, is committed to post-quantum cryptography innovation and has announced a forward-looking ...

Detailed price information for Canalaska Uranium Ltd (CVV-X) from The Globe and Mail including charting and trades.

Product and Platform Validation -- "Our intelligent liveness solution demonstrated the ability to stop sophisticated attack ...

Q1 2026 Earnings Call May 5, 2026 5:00 PM EDTCompany ParticipantsMike Bishop - Investor RelationsScott Bibaud - President, ...

Breakthroughs in AI drug discovery, in vivo cell therapies, and gene editing are moving rapidly from research into clinical practice, supported by regulatory shifts and renewed investor confidence.

On a spring evening at Washington, D.C.’s historic True Reformer Building — the first building in the United States designed, ...